Mayo Clinic Minute: Understanding, treating lymphoma

Hodgkin lymphoma, nodular lymphocyte predominant (high-power view) Credit: Gabriel Caponetti, MD./Wikipedia/CC BY-SA 3.0

Lymphoma is a cancer of the lymphatic system, which is part of the body's germ-fighting network. The main two subtypes are Hodgkin lymphoma and non-Hodgkin lymphoma. Because of breakthrough research, this once fatal diagnosis has been transformed into a curable condition.

In this Mayo Clinic Minute, Dr. Stephen Ansell, a Mayo Clinic hematologist, discusses the different treatment options.

"The cancer in this case is the immune system. So, often we're trying to get the immune system to fight against the cancer. But in this case, the challenge is the cancer is the immune system itself," says Dr. Ansell.

Treatment depends on the type and stage of lymphoma, and may involve chemotherapy, immunotherapy medications, , a or some combination of these.

"In the last 10 years, we've learned that you can actually activate the patient's immune system and have the target the cancer, and that may actually be as effective and sometimes more effective than just using a kind of a nonspecific chemotherapy approach," says Dr. Ansell.

Recent advancements in how lymphoma is treated has helped give more patients hope.

"Treatment is highly successful in the majority of patients," says Dr. Ansell. "Even if the first time around, there are challenges ― there are novel therapies that are coming along or that are already here ― that can impact the outcomes substantially."

Explore further

T-cell receptor diversity may be key to treatment of follicular lymphoma, study finds

©2021 Mayo Clinic News Network
Distributed by Tribune Content Agency, LLC

Citation: Mayo Clinic Minute: Understanding, treating lymphoma (2021, March 31) retrieved 27 July 2021 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors

User comments